Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery.


Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 04 03 2020
revised: 24 04 2020
accepted: 25 04 2020
pubmed: 7 5 2020
medline: 7 2 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

The lipophilic character of peptides can be tremendously improved by hydrophobic ion pairing (HIP) with counterions to be efficiently incorporated into lipid-based nanocarriers (NCs). Herein, HIPs of exenatide with the cationic surfactant tetraheptylammonium bromide (THA) and the anionic surfactant sodium docusate (DOC) were formed to increase its lipophilicity. These HIPs were incorporated into lipid based NCs comprising 41% Capmul MCM, 15% Captex 355, 40% Cremophor RH and 4% propylene glycol. Exenatide-THA NCs showed a log D

Identifiants

pubmed: 32371152
pii: S0939-6411(20)30112-0
doi: 10.1016/j.ejpb.2020.04.025
pii:
doi:

Substances chimiques

Caprylates 0
Drug Carriers 0
Glycerides 0
Lipids 0
Surface-Active Agents 0
Dioctyl Sulfosuccinic Acid 10041-19-7
cremophor 39279-69-1
Polyethylene Glycols 3WJQ0SDW1A
Tacrine 4VX7YNB537
Propylene Glycol 6DC9Q167V3
Glucagon-Like Peptide 1 89750-14-1
Exenatide 9P1872D4OL
monooctanoin VFU0OU98LO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-17

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Ruba Ismail (R)

Institute of Pharmaceutical Technology and Regulatory Affairs, Institute of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary; Institute of Pharmaceutical Technology and Regulatory Affairs, Interdisciplinary Centre of Excellence, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.

Thi Nhu Quynh Phan (TNQ)

Department of Pharmaceutical Technology, Institute of Pharmacy, Leopold-Franzens-University Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria; Faculty of Pharmacy, University of Medicine and Pharmacy, Hue University, Thua Thien Hue, Viet Nam.

Flavia Laffleur (F)

Department of Pharmaceutical Technology, Institute of Pharmacy, Leopold-Franzens-University Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.

Ildikó Csóka (I)

Institute of Pharmaceutical Technology and Regulatory Affairs, Institute of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary; Institute of Pharmaceutical Technology and Regulatory Affairs, Interdisciplinary Centre of Excellence, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.

Andreas Bernkop-Schnürch (A)

Department of Pharmaceutical Technology, Institute of Pharmacy, Leopold-Franzens-University Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria. Electronic address: andreas.bernkop@uibk.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH